|
|
||||||||
Pathogenicity and Medical Microbiology |
Department of Paediatrics, Chang Gung Childrens Hospital, Kweishan 333, Taoyuan, Taiwan1
The Edward Jenner Institute for Vaccine Research, Compton, Newbury, Berkshire, UK2
Department of Microbiology and Immunology3, and Department of Paediatrics4, University of British Columbia, Vancouver, British Columbia, Canada
Author for correspondence: David P. Speert. Tel: +1 604 875 2438. Fax: +1 604 875 2226. e-mail: speert{at}interchange.ubc.ca
Adherence of Burkholderia cepacia to cells of the respiratory tract of patients with cystic fibrosis (CF) appears to be a necessary precondition for colonization and infection. To date, no effective anti-adhesive strategy has been devised for preventing B. cepacia infection in CF patients. It was found in this study that B. cepacia adhered to respiratory epithelial cells both in vitro and in vivo. However, strains with cable-like pili (Cbl) exhibited the typical clump formation on pneumocytes, whereas non-cable piliated strains predominantly showed single-cell adherence. Dextrans (nominally 400010000 Da) significantly inhibited adhesion of B. cepacia to A549 pneumocytes. When compared on an equal weight basis, the nominally 10000 Da dextran was most inhibitory. A dose-dependent inhibitory effect (up to 80 mg ml-1) was observed for most strains. Dextran exerted less of an anti-adhesive effect on the two Cbl+ strains than on the others which were Cbl-. Dextrans appeared to block the adherence in a non-specific fashion, as shown by the observations that the inhibitory effect was readily reversible and oligosaccharides composed of 24 glucose units with the same
-1,6 linkage were not inhibitory. The mean molecular masses of dextrans used in this study, as determined by gel filtration and MS, were approximately 10-fold lower than those indicated by the manufacturers. Our data suggest that dextran of nominal molecular mass 4000 Da at a concentration of 40 mg ml-1 (10 mM according to manufacturers quoted molecular mass) or more may be useful in patients with CF to prevent colonization and infection with B. cepacia.
Keywords: cystic fibrosis
Abbreviations: CF, cystic fibrosis
This article has been cited by other articles:
![]() |
S. McClean and M. Callaghan Burkholderia cepacia complex: epithelial cell-pathogen confrontations and potential for therapeutic intervention J. Med. Microbiol., January 1, 2009; 58(1): 1 - 12. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Thomas and T. Brooks Common oligosaccharide moieties inhibit the adherence of typical and atypical respiratory pathogens J. Med. Microbiol., September 1, 2004; 53(9): 833 - 840. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. L. Gibson, J. L. Burns, and B. W. Ramsey Pathophysiology and Management of Pulmonary Infections in Cystic Fibrosis Am. J. Respir. Crit. Care Med., October 15, 2003; 168(8): 918 - 951. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| INT J SYST EVOL MICROBIOL | MICROBIOLOGY | J GEN VIROL |
| J MED MICROBIOL | ALL SGM JOURNALS | |